HomeZEG • FRA
add
AstraZeneca plc
Previous close
€155.25
Year range
€113.25 - €161.10
Market cap
283.33B USD
Avg Volume
257.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
AZN
0.92%
13.02%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 15.19B | 11.99% |
Operating expense | 8.74B | 4.29% |
Net income | 2.53B | 77.26% |
Net profit margin | 16.67 | 58.31% |
Earnings per share | 1.19 | 14.42% |
EBITDA | 5.21B | 32.83% |
Effective tax rate | 21.86% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.18B | 65.96% |
Total assets | 114.46B | 9.09% |
Total liabilities | 68.48B | 6.81% |
Total equity | 45.97B | — |
Shares outstanding | 1.55B | — |
Price to book | 5.25 | — |
Return on assets | 8.07% | — |
Return on capital | 11.71% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.53B | 77.26% |
Cash from operations | 5.13B | 51.76% |
Cash from investing | -2.00B | -32.17% |
Cash from financing | -2.07B | 49.82% |
Net change in cash | 1.05B | 146.74% |
Free cash flow | 2.80B | 56.04% |
About
Founded
Apr 6, 1999
Headquarters
Website
Employees
94,300